Drug Interactions With Risk of QT-prolongation in a General Hospital
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
In this epidemiological point prevalence study, medication profiles of patients with
haloperidol treatment will be checked for drug interactions with risk of QT-prolongation.
Additional clinical risk factors for developing QT-prolongation and safety measurements will
be documented.
Details
Lead Sponsor:
Katholieke Universiteit Leuven KU Leuven
Collaborator:
Agentschap voor Innovatie door Wetenschap en Technologie